https://clinicaltrials.gov/ct2/show/NCT03971617?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F20%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
Clinical Trial to Evaluate the Safety and Tolerability of Hydrogen in Patients With Parkinson’s Disease
DESCRIPTION:
Condition: Parkinson Disease
Interventions: Drug: Hydrogen; Drug: Placebo oral tablet
Sponsor: Stony Brook University
Recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT03971617
FIRST POSTED:
Mon, 03 Jun 2019 12:00:00 EDT
LAST UPDATE POSTED:
06/03/19 07:42AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03971617?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F20%2F2019&lupd_d=14&sort=nwst